Upamostat is an orally bioavailable, second generation serine protease inhibitor targeting the human urokinase plasminogen activator (uPA) system with potential antineoplastic and antimetastatic activities.
Molecular Weight:
629.81
Purity:
>98%
CAS Number:
[590368-25-5]
Formula:
C32H47N5O6S
Target:
Serine/Threonine Protease
* VAT and and shipping costs not included. Errors and price changes excepted